share_log

醫思健康:通知信函及申請表格給股東 - 公佈中期報告通知

EC HEALTHCARE: Notification Letter and Request Form to Shareholder - Notice of Publication of Interim Report

香港交易所 ·  Dec 28, 2023 03:54
Summary by Moomoo AI
醫思健康(EC Healthcare)於2023年12月20日向股東發出通知,公布中期報告已可在公司及香港交易所網站上獲得。該公司根據上市規則修訂,將自12月31日起改以電子方式發送公司通訊文件,未來不再郵寄紙質通知信函。股東若希望收到印刷版的公司通訊文件,可填寫申請表格並寄回公司香港證券登記處。此外,股東亦可選擇收取電子郵件通知或網上版本的文件。公司提供電話及電郵聯絡方式供股東查詢相關事宜。
醫思健康(EC Healthcare)於2023年12月20日向股東發出通知,公布中期報告已可在公司及香港交易所網站上獲得。該公司根據上市規則修訂,將自12月31日起改以電子方式發送公司通訊文件,未來不再郵寄紙質通知信函。股東若希望收到印刷版的公司通訊文件,可填寫申請表格並寄回公司香港證券登記處。此外,股東亦可選擇收取電子郵件通知或網上版本的文件。公司提供電話及電郵聯絡方式供股東查詢相關事宜。
EC Healthcare (EC Healthcare) issued a notice to shareholders on 20 December 2023 that the interim report is available on the Company and on the HKEX website. In accordance with the revision of the Listing Rules, the Company will send corporate communications electronically from December 31 and will no longer send paper notification letters in the future. Shareholders who wish to receive a printed copy of the company's newsletter may complete the application form and send it back to the Hong Kong Securities Registry. In addition, shareholders may choose to receive an email notification or an online version of the document. The Company provides telephone and email contact information for shareholders' enquiries.
EC Healthcare (EC Healthcare) issued a notice to shareholders on 20 December 2023 that the interim report is available on the Company and on the HKEX website. In accordance with the revision of the Listing Rules, the Company will send corporate communications electronically from December 31 and will no longer send paper notification letters in the future. Shareholders who wish to receive a printed copy of the company's newsletter may complete the application form and send it back to the Hong Kong Securities Registry. In addition, shareholders may choose to receive an email notification or an online version of the document. The Company provides telephone and email contact information for shareholders' enquiries.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more